Company: ELV
Filing Date: 2025-07-17
Form Type: 10-Q
Source: 0001156039-25-000114
Chunk: 41

Company: Elevance Health, Inc.
Filing Date: 2025-07-17
Form: 10-Q
Item: Item 8
Chunk 41
---
%Volatility factor30.00 %28.00 %Quarterly dividend yield0.432 %0.327 %Weighted-average expected life (years)4.454.40The following weighted-average fair values per option or share were determined for the six months ended June 30, 2025 and 2024: Six Months Ended June 3020252024Options granted during the period$107.38 $134.57 Restricted stock awards granted during the period395.28 500.66 Use of Capital – Dividends and Stock Repurchase ProgramWe regularly review the appropriate use of capital, including acquisitions, common stock and debt security repurchases and dividends to shareholders. The declaration and payment of any dividends or repurchases of our common stock or debt is at the discretion of our Board of Directors and depends upon our financial condition, results of operations, future liquidity needs, regulatory and capital requirements and other factors deemed relevant by our Board of Directors. A summary of our cash dividend activity for the six months ended June 30, 2025 and 2024 is as follows: Declaration DateRecord DatePayment DateCashDividendper ShareTotalSix Months Ended June 30, 2025January 22, 2025March 10, 2025March 25, 2025$1.71$386 April 16, 2025June 10, 2025June 25, 2025$1.71$385 Six Months Ended June 30, 2024January 23, 2024March 8, 2024March 22, 2024$1.63$379 April 16, 2024June 10, 2024June 25, 2024$1.63$378 On July 16, 2025, our Audit Committee declared a third quarter 2025 dividend to shareholders of $1.71 per share, payable on September 25, 2025 to shareholders of record at the close of business on September 10, 2025.Under our Board of Directors’ authorization, we maintain a common stock repurchase program. On October 15, 2024, our Audit Committee, pursuant to authorization granted by the Board of Directors, authorized an $8,000 increase to the common stock repurchase program. No duration has been placed on the common stock repurchase program, and we reserve the right to discontinue the program at